The rationale for pairing the two interventions rests on well-characterized but previously separate bodies of evidence. Electrical stimulation of plants has a long, checkered history, stretching back to nineteenth-century electroculture experiments that produced inconsistent results because power delivery could not be controlled precisely. Modern bioelectronics has changed that picture. When a low-intensity electric field is applied to soil or substrate, three transport phenomena come into play: electromigration, which accelerates the movement of mineral cations and anions toward the root absorption zone; electroosmosis, which alters the hydraulic conductivity of the substrate and evens out moisture and nutrient fluxes; and electrophoresis, which can mobilize charged particles, including bacterial cells. At the cellular level, these forces appear to trigger a mild, controlled stress response. Studies cited by the team report upregulation of antioxidant enzyme cascades, induction of heat-shock proteins, activation of membrane-bound H⁺-ATPases, and increased plasma membrane permeability, all of which can accelerate metabolism, photosynthetic efficiency, and nutrient uptake. In one striking recent demonstration, a bioelectronic cellulose-based growth scaffold delivering low-voltage current to seedling roots increased vegetative dry weight by up to fifty percent within two weeks, apparently by enhancing nitrogen metabolism and transcription factors governing root elongation.

Biological stimulation works through an entirely different but complementary toolkit. Plant growth-promoting bacteria benefit their hosts directly by synthesizing phytohormones, most notably indole-3-acetic acid, which stimulates root hair proliferation and expands the functional surface area available for water and nutrient uptake. They also solubilize recalcitrant mineral forms of phosphorus and potassium, fix atmospheric nitrogen, and produce iron-chelating siderophores. Indirectly, they can induce systemic resistance, priming the plant’s own biochemical defenses against drought, heat, and pathogens. The Mexican team hypothesized that a precisely calibrated electric field could serve a dual purpose: physically driving the bacterial inoculant toward the root zone through electroosmotic flow and electrophoresis, while simultaneously priming the plant’s ion transporters to make the most of the microbial nutrient packages once they arrived. If correct, the combination should outperform either intervention alone.

To test this, the researchers ran a unifactorial field design with 125 plants divided into five groups of twenty-five: an untreated control, electrical stimulation alone, biological stimulation alone, and two sequential combinations—electricity followed by bacteria, and bacteria followed by electricity. Treatments were synchronized to three critical phenological stages: pre-flowering in October 2021, fruit set and filling in January 2022, and the onset of commercial harvest in May 2022. Each electrical exposure lasted four hours per stage, delivered through the triangular electrode matrix mirrored on both sides of the root system to guarantee homogeneous field coverage. The bacterial inoculant was applied at a dosage equivalent to just five liters per hectare, a fraction of the ninety to 450 liters per hectare reported in earlier berry trials that relied on microbes alone. Repeated measurements of yield, fruit count, floral buds, structural fruiting twigs, flower-to-fruit conversion, and chlorophyll index were analyzed with generalized linear mixed models, while single-time-point quality metrics were assessed with ANOVA and nonparametric tests.

The headline result came from the sequential treatment in which electricity preceded the bacterial application. Over an eleven-week harvest window, those plants produced a cumulative yield of 1,387 grams per plant, an eleven percent increase over the untreated control’s 1,249 grams. Electrical stimulation alone, by contrast, yielded the lowest output at 1,173 grams per plant, a six percent reduction against the control—evidence that the current, applied without a biological buffer, may induce localized micro-polarization or small zones of substrate depletion under the stringent acidic conditions, pH 4.5 to 5.5, that blueberries demand. Neither yield difference reached statistical significance, and the models showed that time, not treatment, was the dominant factor driving the measured variables. But the pattern was consistent and mechanistically coherent: the electric field appeared to enhance the electroosmotic transport of the liquid inoculant through the coir and wood-chip substrate, accelerating the chemotaxis and spatial spread of the bacteria through the rhizosphere, where their hormone production and nutrient solubilization could take full advantage of the electromigration-concentrated minerals.

Perhaps the most commercially telling finding concerned fruit size rather than total tonnage. The control and electrically stimulated plants produced mostly smaller berries, with the two smallest diameter categories—under 12 millimeters and 13 to 15 millimeters—accounting for 63 percent of the control yield and 64 percent of the electrically stimulated yield. The sequential electricity-then-bacteria treatment flipped that distribution, achieving the highest proportion of large berries in the premium 16-to-18-millimeter class at 33.7 percent while cutting the small-fruit fraction to 19.3 percent. The reverse-sequencing and bacteria-only groups performed similarly, keeping small berries below 19 percent and concentrating roughly 60 to 64 percent of their yield in the medium and large tiers. All treatments held a stable ten percent of jumbo berries above 19 millimeters, except electricity alone, which slipped to eight percent. The researchers interpret this as a shift in resource allocation: instead of initiating a larger number of smaller, carbohydrate-deficient fruits, the stimulated plants redirected metabolic energy into maximizing the volumetric growth of existing fruits, likely through upregulated membrane transporters that let individual berries accumulate more water and photoassimilates during the critical filling phase.

Color, the quality trait most tightly linked to anthocyanin content and consumer appeal, responded most robustly of all. Using a Konica Minolta spectrophotometer, the team measured lightness, the chromatic index, the Hue angle, and the overall color difference from the control baseline. Electrical stimulation alone produced the brightest fruit, with the highest lightness value of 27.10 and the highest chromatic index at 4.16. The bacteria-then-electricity sequence achieved the highest Hue angle at 256.34 degrees, significantly different from the control’s 251.20 degrees. Most strikingly, the electricity-then-bacteria treatment posted a total color divergence of 3.53, a statistically significant shift away from the control. Because blueberry color is conferred by anthocyanins—the flavonoid pigments responsible for the fruit’s celebrated antioxidant activity—these results suggest the mild, controlled stress imposed by the electric field upregulated the phenylpropanoid pathway, accelerating pigment accumulation in the fruit skin and producing berries that are brighter, more uniformly saturated, and potentially richer in health-promoting compounds.

Not every metric moved, and the authors are candid about the boundaries of their results. Sugar accumulation, measured as degrees Brix, stayed within an excellent commercial range of 13.4 to 14.7 across all groups, with the control actually posting the highest value at 14.7, significantly above only the bacteria-then-electricity treatment at 13.5. The team attributes this localized dip to a dilution effect: plants producing larger fruits spread their sugars across a greater tissue volume. Mechanical firmness, measured by compression testing with a TA.XT.plus analyzer, showed no significant differences among treatments, remaining stable at roughly 2.05 to 2.14 newtons for both small and large berries. That stability is good news in itself, because it demonstrates that neither the electrical currents nor the microbial inoculants disrupted the pectin matrix or cell wall integrity that governs shelf life and transport tolerance. Early-season measurements told a similarly nuanced story: bacteria alone achieved the highest flower-to-fruit conversion efficiency at 89.5 percent and the top chlorophyll index at 14.1, while the bacteria-then-electricity group produced an average of 53 fruiting twigs per plant against the control’s 40 to 47, the only variable significantly modified by treatment alone.

The study’s limitations are as instructive as its successes. With only four intensively monitored plants per treatment in a single growing season, the statistical power to detect differences in highly variable cumulative traits like yield was inherently limited, even as biochemically regulated traits like colorimetry achieved significance. The authors acknowledge that multi-season trials with expanded plant cohorts are needed before the eleven percent yield trend can be confirmed for commercial deployment, and that no formal sensory evaluations were conducted to verify whether the color and size improvements translate into consumer preference. Still, the efficiency argument is compelling. Earlier berry studies that achieved larger yield gains—55.9 percent in strawberries, 27 to 29 percent in blueberries with mycorrhizal biostimulants—required inoculum volumes of 90 to 450 liters per hectare, whereas this integrated bio-electric approach reached its result with just five. If subsequent trials bear out the trend, the implication is that a modest, precisely timed electric field can dramatically reduce the biological inputs needed for premium berry production, offering growers a zero-residue, physically driven lever in an industry under pressure to abandon chemical-intensive practices. For now, the Zapopan experiment stands as a proof of concept that the rhizosphere can be engineered with electrons as deliberately as with microbes—a small current, in every sense, with potentially outsized consequences for sustainable agriculture.

Subject of Research: Combined electrical and biological stimulation of blueberry production in a semihydroponic system

Article Title: Electrical and biological stimulation of blueberry production using semihydroponic system

Article References: Barrera-Martínez, I., García-García, G., González-Serrano, D. L., Noguerón-Hernández, F. J., Morales-Martinez, J. C., Contreras-Ramos, S. M., & Bustos-Bustos, E. (2026). Electrical and biological stimulation of blueberry production using semihydroponic system. Discover Agriculture, 4(1), Article 300. https://doi.org/10.1007/s44279-026-00775-1

Image Credits: AI Generated

DOI: 10.1007/s44279-026-00775-1

Keywords: blueberries, electrical stimulation, plant growth-promoting bacteria, semihydroponics, electromigration, electroosmosis, anthocyanins, fruit quality, sustainable agriculture, biostimulants, rhizosphere, Pseudomonas

The core problem with conventional peripheral nerve stimulation lies in its lack of selectivity. When a cuff electrode wrapped around a nerve delivers current, it activates many types of fibers at once: the large, heavily myelinated Aα and Aβ fibers that carry touch and proprioceptive signals toward the spinal cord, the thinner Aδ fibers associated with sharp pain, and the efferent motor fibers that drive muscles. For pain relief, clinicians generally want to activate only the large sensory Aα/Aβ fibers, which can suppress pain transmission through gating mechanisms in the spinal cord. But because electrical stimulation cannot reliably distinguish afferent sensory fibers from efferent motor fibers, the current must be capped at levels that avoid unwanted muscle contractions. That ceiling can leave the therapeutic target population under-activated, blunting the treatment’s analgesic effect.

Optogenetics has long been proposed as an elegant solution. By introducing light-sensitive proteins such as channelrhodopsin 2 (ChR2) into specific populations of neurons, researchers can activate precisely those cells with pulses of light while leaving neighboring fibers untouched. In the new study, the team used transgenic mice expressing ChR2 and recorded compound action potentials (CAPs), the summed electrical signature of many axons firing together, from the sciatic nerve of anaesthetized animals. The results confirmed the selectivity promise: optogenetic stimulation activated Aα/Aβ fibers with impressive precision and produced no motor response at all, something electrical stimulation cannot achieve. For a field struggling to silence pain without triggering twitching limbs or tingling side effects, that selectivity is a major prize.

But there was a catch, and it is a serious one. When the researchers delivered tonic optogenetic stimulation, continuous trains of light pulses lasting up to 60 seconds at clinically relevant frequencies ranging from 4 to 100 Hz, the nerve responses faded dramatically. The optically evoked compound action potentials, or oCAPs, declined in an exponential and strongly frequency-dependent manner, with the statistical analysis showing a highly significant frequency effect (p < 0.001). At stimulation rates above 20 Hz, the response often vanished entirely, leaving no detectable signal even while the light continued to flash. In other words, the very thing that makes optogenetics selective also makes it fragile: the light-activated channels and the fibers themselves fatigue quickly, and the technique as it currently stands is simply untenable for the sustained stimulation that real-world pain therapy demands, even at low frequencies.

Electrical stimulation did not escape unscathed either. The electrically evoked compound action potentials, or eCAPs, also declined over the course of the 60-second stimulation trains, and they did so in a frequency-dependent, dual-phase exponential pattern that the team captured statistically (p < 0.001). This biphasic decay suggests two overlapping processes: a rapid initial drop, likely reflecting activity-dependent changes in axonal excitability such as hyperpolarization or potassium accumulation, followed by a slower secondary decline. Clinicians and device engineers have long observed that nerve responses wane during continuous stimulation, and this study quantifies that phenomenon precisely in the large sensory fiber population that pain therapy seeks to recruit, across the exact frequency range used in clinical peripheral nerve stimulation devices.

The most striking findings emerged when the researchers combined the two modalities. Delivering light and electrical stimulation together produced what the team describes as a facilitated response: the combined electrically and optically evoked CAP, or cCAP, was larger than what either stimulus could achieve alone. Across the entire stimulation period, more than 85 percent of the recorded responses showed this facilitation, and critically, the effect was maintained regardless of stimulation frequency (p = 0.33). The rapid initial reduction in response amplitude for combined stimulation was actually greater than that seen with electrical stimulation alone (p < 0.05), but after that fast phase, the response settled into a similar secondary decline as the electrical-only condition (p = 0.10). The net result, however, was a response that stayed larger and more sustained than either modality could deliver on its own.

Why does combining light and electricity boost the response? The mechanistic picture that emerges from this and earlier work is that the two stimuli act on the fibers through partially independent pathways. Electrical stimulation directly depolarizes the axonal membrane at the electrode, while optogenetic stimulation opens light-gated channels distributed along the ChR2-expressing sensory neurons. When both are applied, the depolarizations summate, preferentially boosting activation in the genetically targeted population of large sensory fibers. Because the electrical component does not fatigue in the same way as the optical one, it appears to prop up the response during the periods when the optically driven component would otherwise collapse. The consequence is a stimulus that retains the selectivity of the optogenetic approach, targeting only the Aα/Aβ fibers, while achieving the sustained responsiveness that pure light-based stimulation lacks.

The clinical implications are considerable. Peripheral nerve stimulation devices are already implanted in patients for chronic pain, but their efficacy is limited by the current ceilings imposed by motor fiber activation and by the inherent non-selectivity of electrical currents. If a hybrid device could deliver a small, safe electrical pulse alongside targeted optical activation of ChR2-expressing sensory fibers, it might achieve stronger and more sustained recruitment of the therapeutic fiber population without crossing into motor territory. The Melbourne team’s demonstration that facilitated responses persist across the full 4 to 100 Hz clinical frequency range, and throughout stimulation trains lasting a full minute, provides exactly the kind of preclinical evidence needed to justify pushing this approach toward translational development. This study adds to growing evidence that combined stimulation could improve the analgesic effect of existing peripheral nerve stimulation methods.

Significant hurdles remain before any such device reaches patients. Optogenetics in humans requires gene delivery, typically via adeno-associated viruses, to introduce light-sensitive proteins into the target neurons, and translating the transgenic mouse approach used here into a safe and durable human therapy is a formidable challenge involving dosing, immune responses and long-term expression. Light delivery to deep peripheral nerves also requires implanted LEDs or optical fibers, adding engineering complexity. The study itself was conducted in isoflurane-anaesthetized mice over relatively short stimulation windows, so questions about responses over hours, days or weeks of continuous use remain open. Ethical oversight was rigorous: all procedures were approved by the St Vincent’s Hospital Animal Ethics Committee in Melbourne and conducted under Australian animal welfare guidelines.

Nevertheless, the study represents a methodical and important step forward. By systematically comparing electrical, optogenetic and combined stimulation across clinically relevant frequencies and durations, and by quantifying the decay dynamics of each with rigorous statistical modeling, Ardren, Wrobel, Matarazzo, Thompson, Fallon, Richardson and their colleagues have given the neuromodulation field a clear-eyed assessment of what each approach can and cannot do. Optogenetics alone, however selective, cannot yet sustain the signals needed for therapy. Electrical stimulation alone, however durable, cannot select its targets. Together, the data suggest, they cover each other’s weaknesses. For the millions of chronic pain patients whose conditions resist every existing treatment, that combination, light and current working in concert, may be the most promising avenue yet for making nerve stimulation devices finally live up to their promise. The research was funded by the National Health and Medical Research Council and the Bionics Institute Incubation Fund, with support from the Victorian Government, and is published open access so that researchers worldwide can build on its findings immediately.

Subject of Research: How optogenetic, electrical and combined stimulation recruit large sensory nerve fibers in the mouse sciatic nerve during sustained neuromodulation for chronic pain treatment.

Article Title: Recruitment of Aα/Aβ fibers during tonic electrical, optogenetic and combined stimulation in the mouse sciatic nerve

Article References: Ardren, M. G., Wrobel, B., Matarazzo, J. V., Thompson, A. C., Fallon, J. B., & Richardson, R. T. (2026). Recruitment of Aα/Aβ fibers during tonic electrical, optogenetic and combined stimulation in the mouse sciatic nerve. BMC Neuroscience. https://doi.org/10.1186/s12868-026-01049-8

Image Credits: AI Generated

DOI: 10.1186/s12868-026-01049-8

Keywords: optogenetics, peripheral nerve stimulation, chronic pain, neuromodulation, sciatic nerve, A-alpha/A-beta fibers, compound action potential, channelrhodopsin, electrical stimulation, neuroengineering, BMC Neuroscience, pain therapy

The current standard of care relies on polypropylene mesh implants, and here the clinical record is troubling. Polypropylene is rigid, hydrophobic, and non-degradable, creating profound biological and mechanical mismatches with soft pelvic tissues. While the mesh provides short-term passive support, its stiffness imposes persistent mechanical overstimulation, and its water-repelling surface promotes nonspecific protein adsorption and inflammatory cell adhesion. The result is often chronic inflammation, foreign body reactions, fibrotic encapsulation, and ultimately mesh curling, displacement, exposure, or erosion. A team of researchers in China, led by Xinting Yang and Quan Lin of Jilin University, has now proposed a radically different approach: a degradable, soft, electrically active scaffold that does not merely hold tissue in place but actively instructs the body to rebuild it. Their work, published in Materials Today Bio, describes an oriented hydrogel designed to mimic the parallel-aligned architecture of skeletal muscle fibers.

The material, named PGZA, is assembled from four biocompatible components: poly(vinyl alcohol), glycyrrhizic acid, zinc ions, and an aniline tetramer grafted onto oxidized alginate. Each ingredient plays a distinct role. Glycyrrhizic acid and zinc ions self-assemble into a first crosslinked network that stabilizes the gel, while simultaneously acting as a synergistic antioxidant system that scavenges reactive oxygen species, molecules known to drive inflammation and push immune cells toward a destructive pro-inflammatory state. The aniline tetramer component supplies electroactivity, enabling electron transfer through conjugated structures and pi-pi interactions. Critically, the entire network is frozen directionally against a chilled brass block, so that ice crystals growing in one direction organize the polymer chains into parallel aligned microchannels, just as muscle fibers align along lines of force in living tissue.

The structural order is not merely aesthetic. Small-angle X-ray scattering revealed a Hermans orientation factor of 0.37 for the directionally frozen gel, compared with 0.01 for a randomly structured control, confirming a genuinely aligned microstructure. That alignment translates directly into performance. In the parallel direction, the optimized PGZA2 formulation, containing 2 milligrams per milliliter of the aniline-grafted alginate, withstood tensile stress of about 229 kilopascals, nearly twice the 122 kilopascals tolerated by the random network version. Its Young’s modulus reached 65 kilopascals with toughness of 181 kilojoules per cubic meter, roughly double the random control in both measures. Conductivity along the alignment direction measured 0.32 siemens per meter, about twenty percent higher than the isotropic version, because ordered conductive chains propagate electrical signals more efficiently. The gel could be stretched to 150 percent and compressed to 60 percent of its original dimensions without breaking, and it retained its mechanical properties after a week in body-temperature fluid, degrading gradually to about 60 percent mass loss over twelve weeks, a timeline that could allow newly formed tissue to assume load-bearing duties as the scaffold disappears.

Electrical stimulation itself has an established role in pelvic medicine, activating signaling cascades such as PI3K/AKT and MAPK/ERK that promote cell migration, differentiation, and extracellular matrix synthesis, and clinical studies have already explored intravaginal stimulation for urinary incontinence. The Jilin team reasoned that a scaffold capable of transmitting such signals along the body’s natural fiber axes would amplify these benefits. In laboratory cultures of fibroblasts, cells grown on the oriented PGZA2 hydrogel showed significantly higher viability by day seven than cells on control materials, and adding electrical stimulation pushed viability higher still. A scratch assay demonstrated the same pattern for migration: the hydrogel accelerated cell movement into wounded areas, and stimulation enhanced the effect further. Under the microscope, cells on the oriented gel aligned preferentially with the microchannels, and with electrical stimulation the alignment became strikingly more pronounced, suggesting that the scaffold and the external field act together as compass and road for migrating tissue-building cells.

The hydrogel also attacked a key biochemical enemy of healing: oxidative stress. Mechanical injury to the pelvic floor triggers accumulation of reactive oxygen species, which inflame the local environment and bias macrophages, the immune system’s tissue-resident first responders, toward the M1 pro-inflammatory phenotype. Using standard DPPH and ABTS radical scavenging assays, the researchers showed that PGZA2 eliminated 66 percent of DPPH radicals and 82 percent of ABTS radicals, far outperforming plain poly(vinyl alcohol) gels. Intracellular reactive oxygen levels in treated cells dropped significantly, and in vitro vascularization assays revealed that the hydrogel, especially with electrical stimulation, promoted the formation of blood vessel-like structures, a crucial capability because regenerating tissue requires a reliable supply of oxygen and nutrients.

To test the material in a living body, the team used a rat model of full-thickness abdominal wall muscle defect, chosen as a surrogate for pelvic floor repair because both tissues are collagen-rich, load-bearing connective structures that heal through similar inflammatory and remodeling phases. Female rats received a one-centimeter circular defect and were divided into untreated controls, and groups receiving the base hydrogel without the electroactive component, the full PGZA2 hydrogel, or PGZA2 plus electrical stimulation at 15 hertz. Transcriptome sequencing of the repaired tissue told a striking story at the level of genes. Compared with controls, 385 genes were upregulated and 266 downregulated, with enrichment in innate immune response pathways, TNF signaling, and IL-17 signaling. Most tellingly, Ifit3, a marker of inflammatory M1 macrophages, was significantly downregulated, while Lgals9, a marker of reparative M2 macrophages, was significantly upregulated, indicating that the treatment had shifted the local immune environment from a state of chronic aggression toward one of resolution and reconstruction.

Histology confirmed the molecular signals. By six weeks after surgery, hematoxylin and eosin staining showed that tissue from the PGZA2 plus stimulation group was the most compact and organized, with the fewest inflammatory infiltrates. Elastica Van Gieson staining revealed the densest network of mature elastic fibers in that group, and Masson’s trichrome staining showed the greatest amount of well-structured collagen, in contrast to the disorganized early fibrosis seen in lesser formulations. Immunofluorescence sealed the case: TNF-alpha, the signature pro-inflammatory cytokine, was most strongly suppressed in the combined treatment group, while TGF-beta, a driver of anti-inflammatory repair and matrix remodeling, reached its highest expression there. The reciprocal cytokine pattern, together with the macrophage marker shift, indicates that the scaffold converts a hostile inflammatory wound bed into a pro-regenerative one.

The authors are candid about the road ahead. The abdominal wall model, while relevant, is not the pelvic cavity, and the long-term fixation stability, synchronization of degradation with tissue ingrowth, and functional restoration in anatomically accurate models remain to be demonstrated. Clinically, they envision the hydrogel first serving as an adjunct at mesh-tissue interfaces during procedures such as laparoscopic lateral suspension, providing compliant early support and calming inflammation while permanent constructs maintain suspension, before full replacement of mesh can be considered. They also sketch a wireless future in which capacitive or inductive coupling, or piezoelectric and triboelectric materials embedded in the gel, could harvest energy from body movement or ultrasound to deliver electrical cues without implanted batteries. If those steps succeed, the muscle-mimicking hydrogel would represent a genuine paradigm shift, moving pelvic floor repair away from passive structural substitution and toward active biological guidance, in which the implant’s job is to make itself unnecessary.

Subject of Research: An oriented, conductive, immunomodulatory hydrogel designed to treat pelvic organ prolapse by regenerating pelvic floor connective tissue

Article Title: Oriented hydrogel biomimicking muscle fibers to treat pelvic organ prolapse via integrated immunomodulation and electrical stimulation

Article References: Yang, X., Li, H., Feng, Y., Wei, C., Guo, Y., Yang, B., Xu, T., & Lin, Q. (2026). Oriented hydrogel biomimicking muscle fibers to treat pelvic organ prolapse via integrated immunomodulation and electrical stimulation. Materials Today Bio, 41, Article 103658. https://doi.org/10.1016/j.mtbio.2026.103658

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103658

Keywords: pelvic organ prolapse, hydrogel, tissue engineering, electrical stimulation, immunomodulation, biomaterials, collagen remodeling, regenerative medicine, macrophage polarization, polypropylene mesh, glycyrrhizic acid, reactive oxygen species